Multi-detector computed tomography (MDCT) evaluation of synchronous renal cell carcinoma and other solid malignancies

Egyptian Journal of Radiology and Nuclear Medicine

Table 1 Characteristics of 31 patients with synchronous RCC and other solid malignancies

Case No	Age/sex	Renal cell carcinoma				Extra-renal malignancy
		TNM staging				Site	TNM staging
		T	N	M	Stage	Site	T	N	M	Stage
1	58/M	T1a	N0	M0	I	HCC	B (BCLC)
2	67/M	T1b	N0	M0	I	HCC	B (BCLC)
3	58/M	T1b	N0	M0	I	HCC	B (BCLC)
4	65/M	T3a	N0	M0	III	HCC	C (BCLC)
5	55/F	T1a	N0	M0	I	HCC	A (BCLC)
6	56/F	T1a	N0	M0	I	HCC	A (BCLC)
7	58/F	T1a	N0	M0	I	HCC	A (BCLC)
8	73/M	T1a	N0	M0	I	HCC	A (BCLC)
9	64/M	T3a	N0	M0	III	HCC	A (BCLC)
10	68/M	T1a	N0	M0	I	HCC	A (BCLC)
11	45/F	T1a	N0	M0	I	Breast	T2	N0	M0	IIA
12	55/F	T1b	N0	M0	I	Breast	T4b	N1	M0	IIIC
13	63/F	T1b	N0	M0	I	Breast	T1c	N0	M0	I
14	65/F	T1b	N0	M0	I	Breast	T2	N0	M0	IIA
15	60/F	T1b	N0	M0	I	NHL	I (Ann Arbor staging)
16	65/F	T3a	N0	M0	III	NHL	III (Ann Arbor staging)
17	53/M	T1b	N0	M0	I	NHL	II (Ann Arbor staging)
18	62/M	T1a	N0	M0	I	NHL	III (Ann Arbor staging)
19	63/M	T1a	N0	M0	I	Lung	T1b	N2	M0	IIIA
20	70/M	T1a	N0	M0	I	Lung	T4	N0	M0	IIIA
21	52/M	Local recurrent with para-aortic malignant LN				Lung	T4	N2	M0	IIIB
22	68/F	T1a	N0	M0	I	Colon	T4a	N1b	M0	IIIB
23	68/M	T1b	N0	M0	I	Colon	T4a	N1b	M0	IIIB
24	58/M	T1a	N0	M0	I	Colon	T4a	N2b	M0	IIIC
25	73/M	T1a	N0	M0	I	Prostate	T3b	N1	M1a	IV
26	80/M	T1b	N0	M0	I	Prostate	T2b	N0	M0	IIA
27	75/M	T1a	N0	M0	I	U.B	T3b	N2	M0	IV
28	74/M	T1a	N0	M0	I	Peri-ampullary	T1	N0	M0	IA
29	73/M	T1b	N0	M0	I	Mucoepidermoid*	T0	N2	M0	IVA
30	75/M	T1a	N0	M0	I	Skin Sq.C.C	T1	N0	M0	I
31	36/M	T3a	N0	M0	III	M.H.E*	Locally advanced

BCLC; Barcelona Clinic Liver Cancer staging classification, HCC; Hepatocellular carcinoma, NHL; Non-Hodgkin lymphoma, M.H.E*; Malignant hemangioendothelioma, Mucoepidermoid*; Mucoepidermoid carcinoma of left upper cervical region. RCC; Renal cell carcinoma, Sq.C.C.; Squamous cell carcinoma, U.B.; Urinary bladder